Indivior PLC (INDV)

NASDAQ: INDV · IEX Real-Time Price · USD
10.41
-0.05 (-0.48%)
Jul 19, 2024, 4:00 PM EDT - Market closed
-0.48%
Market Cap 1.44B
Revenue (ttm) 1.12B
Net Income (ttm) 5.00M
Shares Out 138.03M
EPS (ttm) 0.02
PE Ratio 520.50
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 158,357
Open 10.39
Previous Close 10.46
Day's Range 10.30 - 10.42
52-Week Range 9.14 - 24.78
Beta 0.11
Analysts Strong Buy
Price Target 24.00 (+130.55%)
Earnings Date Jul 29, 2024

About INDV

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUB... [Read more]

Sector Healthcare
Founded 1994
Employees 1,164
Stock Exchange NASDAQ
Ticker Symbol INDV
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for INDV stock is "Strong Buy" and the 12-month stock price forecast is $24.0.

Price Target
$24.0
(130.55% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Indivior PLC - INDV

NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV).  Such investors are advised to co...

4 hours ago - GlobeNewsWire

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm Today!

NEW YORK CITY, NY / ACCESSWIRE / July 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

1 day ago - Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Indivior PLC - INDV

NEW YORK , July 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Indivior PLC ("Indivior" or the "Company") (NASDAQ: INDV). Such investors are advised to contac...

2 days ago - PRNewsWire

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Stockholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

2 days ago - Accesswire

Indivior PLC (INDV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK--(BUSINESS WIRE)---- $INDV #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC (“Indivior” or “the...

3 days ago - Business Wire

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Stockholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

3 days ago - Accesswire

INDV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

4 days ago - Accesswire

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

5 days ago - Accesswire

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Shareholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

6 days ago - Accesswire

INDV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

8 days ago - Accesswire

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

9 days ago - Accesswire

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Indivior PLC and Encourages Investors to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV...

10 days ago - Accesswire

S&P 500 Edges Higher; Indivior Shares Plummet

U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.1% on Tuesday.

11 days ago - Benzinga

INDV Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Indivior PLC for Potential Securities Law Violations

MONSEY, N.Y., July 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Indivior PLC (Nasdaq: INDV) (“Indivior”) has violated the federal securities laws after the...

11 days ago - GlobeNewsWire

What's Going On With Addiction And Mental Illnesses-Focused Indivior Stock On Tuesday?

Tuesday, Indivior Plc INDV announced a downward revision of its profit forecast for the year while deciding to cease sales of its schizophrenia drug Perseris.

11 days ago - Benzinga

Indivior Cuts 2024 Outlook, Joins BP And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 50 points on Tuesday.

Other symbols: BP
11 days ago - Benzinga

Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WI...

11 days ago - PRNewsWire

Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Ca

Large reductions in the incidence of simulated cardiac arrest caused by potentially lethal doses of fentanyl or carfentanil were observed following a single IN dose of OPVEE compared to a single dose ...

4 weeks ago - PRNewsWire

Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder

Double-blind, placebo-controlled study aims to measure safety and efficacy of INDV-2000 over 3 months in participants with moderate to severe Opioid Use Disorder. INDV-2000 is an investigational non-o...

5 weeks ago - PRNewsWire

Opioid Use Disorder in the 7MM: Epidemiology Insights and Forecast 2024-2034 Featuring Detailed Analysis of Marketed and Late-Stage Pipeline Drugs, Including Subutex and INDV-2000 (Indivior)

Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ResearchAnd...

6 weeks ago - GlobeNewsWire

Indivior CEO Mark Crossley on combatting the opioid crisis with new drugs

Mark Crossley, Indivior CEO, joins 'Squawk Box' to discuss what Indivior does, how much the company's drugs costs, and usage of the company's drugs.

2 months ago - CNBC Television

Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance

RICHMOND, Va., May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation of the expected primary listing of the Company...

2 months ago - PRNewsWire

Indivior Announces Q1 2024 Financial Results

SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024.

3 months ago - PRNewsWire

Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone

This head-to-head pharmacodynamic study in healthy volunteers examined the ability of both OPVEE and intranasal naloxone to reverse opioid-induced respiratory depression, which is the shallow and slow...

4 months ago - PRNewsWire

Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation

RICHMOND, Va. , Feb. 29, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, today announced that its subsidiary, Indivior Inc., has received final Cour...

5 months ago - PRNewsWire